Publications by authors named "Corey Mallett"

Claim this Profile
I
Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants.
Kirill Vasilev, Irene Hoxie, Eduard Puente-Massaguer, Joshua Yueh, Disha Bhavsar, Corey P Mallett

NPJ Vaccines· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of cross-reactive antigens with machine learning and high-throughput experimental evaluation.
Chelsy Chesterman, Thomas Desautels, Luz-Jeannette Sierra, Kathryn T Arrildt, Adam Zemla, Corey P Mallett

Front Bioinform· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based Design of Chimeric Influenza Hemagglutinins to Elicit Cross-group Immunity.
Karla M Castro, Reyhaneh Ayardulabi, Sarah Wehrle, Hongrui Cui, Sandrine Georgeon, Corey P Mallett

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computationally designed stem-epitope mimetics elicit broadly reactive antibodies.
Sarah Wehrle, Andreas Scheck, Laura Reusch, Flavio Matassoli, Sandrine Georgeon, Corey P Mallett

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.
Lionel Sacconnay, Jonathan De Smedt, Vera Rocha-Perugini, Edison Ong, Romuald Mascolo, Corey P Mallett

Sci Transl Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity.
James A Williams, Marco Biancucci, Laura Lessen, Sai Tian, Ankita Balsaraf, Corey P Mallett

Sci Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity.
Min Z Levine, Crystal Holiday, Yaohui Bai, Weimin Zhong, Feng Liu, Corey P Mallett

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Pandemic influenza vaccine approaches: Current status and future directions.
Michael Schotsaert, Rebecca Jane Cox, Corey P Mallett

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, Pierre Van Damme, Adolfo García-Sastre, Corey P Mallett

Lancet Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.
Giulietta Maruggi, Corey P Mallett, Jason W Westerbeck, Tiffany Chen, Giuseppe Lofano

Mol Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets.
Daniel Stadlbauer, Leon de Waal, Edith Beaulieu, Shirin Strohmeier, Edwin J B Veldhuis Kroeze, Corey P Mallett

NPJ Vaccines· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F.
Wayne Harshbarger, Sai Tian, Newton Wahome, Ankita Balsaraf, Deep Bhattacharya, Corey P Mallett

PLoS Pathog· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.
Giuseppe Lofano, Corey P Mallett, Sylvie Bertholet, Derek T O'Hagan

NPJ Vaccines· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.
Éric Destexhe, Émilie Grosdidier, Adèle Bouhraoua, Catherine Thirion-Delalande, Badiaa Bouzya, Corey P Mallett

Regul Toxicol Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine.
Rushit N Lodaya, Amey P Kanitkar, Kristian Friedrich, Dawn Henson, Ryan Yamagata, Corey P Mallett

J Control Release· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad A Behzadi, Damien Friel, Corey P Mallett

NPJ Vaccines· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.
Min Z Levine, Crystal Holiday, Stacie Jefferson, F Liaini Gross, Feng Liu, Corey P Mallett

NPJ Vaccines· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
Angela Choi, Badiaa Bouzya, Klaus-Daniel Cortés Franco, Daniel Stadlbauer, Arvind Rajabhathor, Corey P Mallett

Immunohorizons· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
Rob Lambkin-Williams, Colin Gelder, Richard Broughton, Corey P Mallett, Anthony S Gilbert

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice.
Karen K Yam, Angela Brewer, Virginie Bleau, Édith Beaulieu, Corey P Mallett

Hum Vaccin Immunother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.
Camille Planty, Corey P Mallett, Kevin Yim, Jorge C G Blanco, Marina Boukhvalova

Hum Vaccin Immunother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.
Raffael Nachbagauer, David Kinzler, Angela Choi, Ariana Hirsh, Edith Beaulieu, Corey P Mallett

NPJ Vaccines· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Yacine Abed, Xavier Bouhy, Arnaud G L'Huillier, Chantal Rhéaume, Andrés Pizzorno, Corey Mallett

Antiviral Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets.
Julie Ann, Yacine Abed, Edith Beaulieu, Xavier Bouhy, Marie-Hélène Joly, Corey Mallett

Influenza Other Respir Viruses· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
Karen K Yam, Jyotsana Gupta, Elizabeth K Allen, Kayla R Burt, Édith Beaulieu, Corey P Mallett

Vaccine· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis